Skip to main content

Permira Adds Philippe Houssiau As Senior Adviser

Private equity firm Permira has added Philippe Houssiau as a Senior Adviser, focusing on healthcare.

Houssiau was previously at PwC as a Partner and CEO at Agfa Healthcare; he was also the former Chairman of 4ways and has been an Operating Partner at HgCapital.

Silvia Oteri, Partner and Head of Healthcare at Permira, says: “Philippe’s knowledge, expertise and network which intersect both healthcare and technology will support our healthcare investing efforts, particularly our increased focus in the healthcare technology space. We will benefit greatly from his experience as we build on our success of investing behind advanced technologies within traditional areas of healthcare, including robotics at Corin and artificial intelligence at I-Med.”

Houssiau currently serves as Non-Executive Chairman of Althea Group, a European vendor-independent provider of healthcare technology management and a Permira funds’ portfolio company, and in a leadership role with MAK System, a provider of software services for the management of blood and cellular products.

Houssiau added: “I’m delighted to be joining Permira at this exciting time for the firm. The team has built a strong track record of investing across the healthcare sector and I look forward to helping source and develop interesting proprietary investment opportunities globally, as well as supporting the Permira Healthcare portfolio companies in their strategic initiatives.”

The Permira funds have completed several investments in the healthcare sector and have deployed around €3.5bn in the sector to date. The funds most recently acquired Neuraxpharm, a European specialty pharmaceutical company focused on the treatment of the central nervous system (CNS). Prior to that, the Permira funds acquired Cambrex in 2019, a pharma CDMO, Quotient Sciences in the same year, a provider of specialist drug development services and LSNE, a contract development and manufacturing organisation specialising in sterile lyophilisation and fill & finish. Other funds’ portfolio companies in the sector include Althea, Corin, a tech enabled orthopaedic implant company and I-Med, a network of radiology clinics in Australia.


© The Sortino Group Ltd

All Rights Reserved. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or scanning or otherwise, except under the terms of the Copyright, Designs and Patents Act 1988 or under the terms of a licence issued by the Copyright Licensing Agency or other Reprographic Rights Organisation, without the written permission of the publisher. For more information about reprints from AlphaWeek, click here.